arrow
P

Philippe Colson

Centre National de la Recherche Scientifique
H指数:74
被引数:3.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Real-World Experience With Lenacapavir and/or Fostemsavir as Emerging Therapies for the Management of Multidrug-Resistant HIV-1 in Southeastern France

法国东南部地区使用Lenacapavir和/或Fostemsavir作为新兴疗法管理多药耐药HIV-1的实践经验

2026-09-120
OA
Epidemiological, Clinical and Viral Genomic Features of Influenza Virus Infections Among Pilgrims During the Grand Magal of Touba Over 7 Years (2018–2024)

2018–2024年图巴大玛加尔朝圣期间流感病毒感染的流行病学、临床和病毒基因组特征

2026-08-310
OAAI
Genomic characterization of SARS-CoV-2 variants circulating in the population of Bangui, Central African Republic (CAR) in 2022

2022年中非共和国班吉市人群中流行的SARS-CoV-2变体的基因组特征分析

2026-05-280
OAAI
Implementation of a Multiplex PCR Amplification System Combined With Next-Generation Genome Sequencing to Decipher the Circulation of Human Coronavirus 229E Lineages in Southern France

实施一种结合下一代基因组测序的多重PCR扩增系统,以解析法国南部人冠状病毒229E谱系的流行情况

2025-10-230
OAAI
Long-Term Sewage Survey of SARS-CoV-2, Influenza A and Respiratory Syncytial Virus (RSV), and Correlation to Human Cases in a City with One Million Inhabitants

对SARS-CoV-2、Influenza A和Respiratory Syncytial Virus (RSV)的长期污水监测,及其与一座百万人口城市中人类病例的相关性

2025-09-290
OAAI
Significant rise of Chlamydia pneumoniae infection in 2024 in Marseille, France

2024年法国马赛地区肺炎衣原体(Chlamydia pneumoniae)感染显著上升

2025-06-010
OAAI
RETRACTION: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial

撤稿:羟氯喹和阿奇霉素作为COVID-19的治疗方法:一项开放标签非随机临床试验的结果

2025-01-010
PRE